B2S Life Sciences
B2S Life Sciences is a biotherapeutic enablement company delivering bioanalytical solutions for biotherapeutic drug candidates and diagnostics.
Last updated September 1, 2026
AI crawler reads
2requests
1companies- Anthropic2
- Profile
- 2
- Controversies
- 0
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
B2S Life Sciences is a biotherapeutic enablement company. It leverages combined expertise in custom critical reagents and regulated bioanalysis to deliver bioanalytical solutions for biotherapeutic drug candidates and diagnostics. The company provides custom critical reagents, lab solutions, data analytics, drug development and consulting services.
History
B2S Life Sciences was founded in 2003 by Ronald Bowsher, PhD, Wendell Smith, PhD and Rocco Brunelle, MS as Bowsher, Brunelle and Smith, LLC (dba B2S Consulting) to provide clients with bioanalytical and statistical services. The company has evolved over time, with milestones in 2014, 2015, 2016, 2018, 2019, 2022, and 2023.
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/b2s-life-sciences · Editorial policy · How profiles are compiled